Contreras Villamizar Kateir Mariel, Afanador Rubio Diana Carolina, González González Camilo Alberto, García Padilla Paola Karina, Rodríguez Sánchez Martha Patricia
Nephrology Unit, Internal Medicine Department, Hospital Universitario San Ignacio, Medical School, Pontificia Universidad Javeriana, Colombia.
Nephrology Unit, Internal Medicine Department, Hospital Universitario San Ignacio, Medical School, Pontificia Universidad Javeriana, Colombia.
Int J Surg Case Rep. 2019;57:19-21. doi: 10.1016/j.ijscr.2019.02.041. Epub 2019 Mar 5.
Morbid obesity in chronic kidney disease patients on hemodialysis limits access to renal transplantation. We report here a case of a surgical procedure for weight reduction in a hemodialysis patient and adjustment of dry weight through bioelectrical impedance.
A 44-year-old male with CKD on hemodialysis for 26 years. After 3 years on dialysis, he underwent a cadaveric kidney transplant. However, after 8 years of transplant, he loses the kidney graft and returns to dialysis treatment. The patient's BMI increased to 42 kg/m and he had difficult-to-control hypertension and severe sleep apnea. Behavioral, nutritional and pharmacologic measures were not sufficient to achieve an adequate weight control. Thus, a surgical procedure for weight reduction was considered. The patient underwent a laparoscopic gastric sleeve without any complications. Dry weight was adjusted through bioelectrical impedance before each hemodialysis session. The patient did not display hypotension, cramps, or fluid overload. After a 30 kg weight loss, the patient's BMI was 28.3 kg/m, allowing registration on the kidney transplant waitlist.
Obesity in CKD restricts access to kidney transplant waitlist. Bariatric surgery has proven to be safe and effective for sustained weight loss and it seems that the fact that a patient is dialysis dependent does not independently increase post-operatory complications.
Surgical procedures for weight reduction in dialysis patients does not independently increase the risk for adverse outcomes after bariatric surgery. The estimation of DW through BIA is an effective method for avoiding complications generated by excessive or deficient ultrafiltration.
接受血液透析的慢性肾脏病患者的病态肥胖限制了肾移植的机会。我们在此报告一例血液透析患者减重手术及通过生物电阻抗调整干体重的病例。
一名44岁男性,接受血液透析治疗慢性肾脏病26年。透析3年后,他接受了尸体肾移植。然而,移植8年后,他失去了肾移植,重新开始透析治疗。患者的体重指数(BMI)增至42kg/m²,患有难以控制的高血压和严重的睡眠呼吸暂停。行为、营养和药物治疗措施不足以实现充分的体重控制。因此,考虑进行减重手术。患者接受了腹腔镜胃袖状切除术,未出现任何并发症。在每次血液透析治疗前通过生物电阻抗调整干体重。患者未出现低血压、痉挛或液体过载。体重减轻30kg后,患者的BMI为28.3kg/m²,从而得以登记进入肾移植等待名单。
慢性肾脏病患者的肥胖限制了进入肾移植等待名单的机会。减肥手术已被证明对持续减重是安全有效的,而且患者依赖透析这一事实似乎并不会独立增加术后并发症的发生率。
透析患者的减重手术并不会独立增加减肥手术后不良结局的风险。通过生物电阻抗评估干体重是避免超滤过多或不足所产生并发症的有效方法。